| Literature DB >> 31727541 |
Jodi Warman Chardon1, Jordi Díaz-Manera2, Giorgio Tasca3, Carsten G Bönnemann4, David Gómez-Andrés5, Arend Heerschap6, Eugenio Mercuri7, Francesco Muntoni8, Anna Pichiecchio9, Enzo Ricci10, Maggie C Walter11, Michael Hanna12, Heinz Jungbluth13, Jasper M Morrow14, Roberto Fernández-Torrón15, Bjarne Udd16, John Vissing17, Tarek Yousry18, Susana Quijano-Roy19, Volker Straub20, Robert Y Carlier21.
Abstract
Whole-body magnetic resonance imaging has emerged as a useful imaging tool in diagnosing and characterizing the progression of myopathies and muscular dystrophies. Whole-body MRI indications and diagnostic efficacy are becoming better defined with the increasing number of cases, publications and discussions within multidisciplinary working groups. Advanced Whole-body MRI protocols are rapid, lower cost, and well-tolerated by patients. Accurate interpretation of muscle Whole-body MRI requires a detailed knowledge of muscle anatomy and differential pattern of involvement in muscle diseases. With the surge in recently identified novel genetic myopathies, Whole-body MRI will become increasingly useful for phenotypic validation of genetic variants of unknown significance. In addition, Whole-body MRI will be progressively used as a biomarker for disease progression and quantify response to therapy with the emergence of novel disease modifying treatments. This review outlines Whole-body MRI indications and updates refined protocols and provides a comprehensive overview of the diagnostic utility and suggested methodology of Whole-body MRI for pediatric and adult patients with muscle diseases.Entities:
Keywords: Congenital myopathy; Inflammatory myopathy; Inherited myopathy; Limb girdle muscular dystrophy; Magnetic resonance imaging; Whole-body MRI
Mesh:
Year: 2019 PMID: 31727541 DOI: 10.1016/j.nmd.2019.08.011
Source DB: PubMed Journal: Neuromuscul Disord ISSN: 0960-8966 Impact factor: 4.296